scPharmaceuticals Inc. Files 8-K on Financials
| Field | Detail |
|---|---|
| Company | Scpharmaceuticals Inc. |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: SCPH
TL;DR
SCPH filed an 8-K on 5/14 detailing financials. Check it out.
AI Summary
On May 14, 2025, scPharmaceuticals Inc. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 25 Burlington Mall Road, Suite 203, Burlington, MA 01803.
Why It Matters
This filing provides investors with crucial updates on scPharmaceuticals Inc.'s financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant events.
Key Players & Entities
- scPharmaceuticals Inc. (company) — Registrant
- May 14, 2025 (date) — Date of report
- 25 Burlington Mall Road, Suite 203, Burlington, MA 01803 (location) — Principal executive offices address
- 001-38293 (company_id) — SEC File Number
- 46-5184075 (company_id) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of scPharmaceuticals Inc., and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on May 14, 2025.
What is the official name of the company filing this report?
The official name of the company filing this report is scPharmaceuticals Inc.
Where are scPharmaceuticals Inc.'s principal executive offices located?
scPharmaceuticals Inc.'s principal executive offices are located at 25 Burlington Mall Road, Suite 203, Burlington, Massachusetts 01803.
What is the SEC file number for scPharmaceuticals Inc.?
The SEC file number for scPharmaceuticals Inc. is 001-38293.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding scPharmaceuticals Inc..